ACM
TCRR

Aquatic Capital Management’s TCR2 Therapeutics Inc. Common Stock TCRR Stock Holding History

Aquatic Capital Management’s Portfolio TCRR Stock Details TCRR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-13,400
Closed -$24K – 1932
2022
Q3 		$24K Buy
+13,400
New +$38.9K ﹤0.01% 981
2022
Q2 		– Sell
-1,000
Closed -$3K – 1682
2022
Q1 		$3K Sell
1,000
-6,700
-87% -$21.1K ﹤0.01% 944
2021
Q4 		$36K Buy
+7,700
New +$48.1K 0.07% 407

Other funds holding TCRR

MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NM
Newtyn Management New York $936M AUM 27.23% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Aquatic Capital Management's TCRR Position: Q4 2022 in Review

Aquatic Capital Management sold out of TCR2 Therapeutics Inc. Common Stock (TCRR) in Q4 2022, closing a stake of 13,400 shares — an estimated $24K sold.

Aquatic Capital Management first reported a position in TCRR in Q4 2021 and held it in 3 quarters. The position peaked at $36K in Q4 2021. 63 funds tracked by Wall St. Rank hold TCRR as of Q4 2022.

  • Aquatic Capital Management reported no remaining TCR2 Therapeutics Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Aquatic Capital Management sold 13,400 TCR2 Therapeutics Inc. Common Stock shares in Q4 2022, an estimated $24K.
  • Aquatic Capital Management first reported a position in TCR2 Therapeutics Inc. Common Stock in Q4 2021 and held it in 3 quarters.
  • Aquatic Capital Management's TCR2 Therapeutics Inc. Common Stock position peaked at $36K in Q4 2021.
  • 63 funds tracked by Wall St. Rank held TCR2 Therapeutics Inc. Common Stock as of Q4 2022.

Based on Aquatic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.